Posted by Michael Wonder on 13 Jun 2022
FDA approves first systemic treatment for alopecia areata
13 June 2022 - Today, the U.S. FDA approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a disorder that often appears as patchy baldness and affects more than 300,000 people in the U.S. each year.
Today’s action marks the first FDA approval of a systemic treatment (i.e. treats the entire body rather than a specific location) for alopecia areata.
